Mid-luteal phase injection of subcutaneous leuprolide acetate improves live delivered pregnancy and implantation rates in younger women undergoing in vitro fertilization-embryo transfer (IVF-ET)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.